BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19223151)

  • 1. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
    Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM
    J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
    Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
    Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of attributional processes concerning medication taking on return of fear.
    Powers MB; Smits JA; Whitley D; Bystritsky A; Telch MJ
    J Consult Clin Psychol; 2008 Jun; 76(3):478-90. PubMed ID: 18540741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
    Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
    J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting in vivo exposure with fear antagonistic actions: a preliminary test.
    Wolitzky KB; Telch MJ
    Behav Ther; 2009 Mar; 40(1):57-71. PubMed ID: 19187817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
    Smits JA; Rosenfield D; Davis ML; Julian K; Handelsman PR; Otto MW; Tuerk P; Shiekh M; Rosenfield B; Hofmann SG; Powers MB
    Biol Psychiatry; 2014 Jun; 75(11):840-6. PubMed ID: 24237691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the judicious use of safety behaviors improve the efficacy and acceptability of exposure therapy for claustrophobic fear?
    Deacon BJ; Sy JT; Lickel JJ; Nelson EA
    J Behav Ther Exp Psychiatry; 2010 Mar; 41(1):71-80. PubMed ID: 19892318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fear activation and distraction during the emotional processing of claustrophobic fear.
    Telch MJ; Valentiner DP; Ilai D; Young PR; Powers MB; Smits JA
    J Behav Ther Exp Psychiatry; 2004 Sep; 35(3):219-32. PubMed ID: 15262218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.
    Berry AC; Rosenfield D; Smits JA
    Depress Anxiety; 2009; 26(1):22-7. PubMed ID: 18781661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone renders one-session exposure therapy less effective: a controlled pilot study.
    Kozak AT; Spates CR; McChargue DE; Bailey KC; Schneider KL; Liepman MR
    J Anxiety Disord; 2007; 21(1):142-52. PubMed ID: 16647240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavioral therapy for public-speaking anxiety using virtual reality for exposure.
    Anderson PL; Zimand E; Hodges LF; Rothbaum BO
    Depress Anxiety; 2005; 22(3):156-8. PubMed ID: 16231290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evaluation of a broad-spectrum cognitive-behavioral group therapy for anxiety.
    Norton PJ; Hope DA
    J Behav Ther Exp Psychiatry; 2005 Jun; 36(2):79-97. PubMed ID: 15814078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions.
    Tillfors M; Carlbring P; Furmark T; Lewenhaupt S; Spak M; Eriksson A; Westling BE; Andersson G
    Depress Anxiety; 2008; 25(8):708-17. PubMed ID: 18729147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and cognitive group treatment for fear of flying: a randomized controlled trial.
    Van Gerwen LJ; Spinhoven P; Van Dyck R
    J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):358-71. PubMed ID: 16828460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up.
    Prasko J; Dockery C; Horácek J; Houbová P; Kosová J; Klaschka J; Pasková B; Praskova H; Seifertová D; Záleský R; Höschl C
    Neuro Endocrinol Lett; 2006 Aug; 27(4):473-81. PubMed ID: 16891998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of imagery in the maintenance and treatment of snake fear.
    Hunt M; Bylsma L; Brock J; Fenton M; Goldberg A; Miller R; Tran T; Urgelles J
    J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):283-98. PubMed ID: 16473325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific phobias.
    Hamm AO
    Psychiatr Clin North Am; 2009 Sep; 32(3):577-91. PubMed ID: 19716991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.